mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.01 |
mRNA |
SCH-79797 |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.01 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.02 |
mRNA |
SKI-II |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.02 |
mRNA |
ceranib-2 |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.02 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.02 |
mRNA |
I-BET151 |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.02 |
mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.02 |
mRNA |
TPCA-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.02 |
mRNA |
lomeguatrib |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.02 |